NEW YORK--(BUSINESS WIRE)--July 31, 2006--ImClone Systems Incorporated (NASDAQ: IMCL - News) today announced that its motion for summary judgment in the patent infringement litigation with Repligen Corporation and MIT was denied by the U.S. District Court in Massachusetts. In the summary judgment motion, ImClone Systems sought to dismiss all claims of Repligen and MIT on the basis that the patent rights at issue were exhausted as a matter of law. The case will now proceed to trial on the merits of ImClone Systems’ other defenses, and the Company intends to vigorously defend its position that, among other things, it does not infringe the subject patent.
